Phase II multicenter, randomized, double-blind study of recombinant mutated human tumor necrosis factor-α in combination with chemotherapies in cancer patients
Meng Li, Tianjiao Xu, Zhao Zhang, Xiaochang Xue, Cun Zhang, Xin Qin, Weina Li, Qiang Hao, Wei Zhang, Yingqi ZhangVolume:
103
Year:
2012
Language:
english
Pages:
8
DOI:
10.1111/j.1349-7006.2011.02153.x
File:
PDF, 183 KB
english, 2012